Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, Bristol-Myers Squibb Expand Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec, Bristol-Myers Squibb Expand Alliance

Inclusion of additional cell lines triggers $6 million payment from BMS

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evotec SE and Bristol-Myers Squibb have expand their collaboration to include additional cell lines, triggering a $6 million payment from BMS. 

Evotec and Celgene, a Bristol-Myers Squibb company, initiated the collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases with unmet medical need. This collaboration uses an innovative approach to the discovery and development of novel medicines by leveraging several of Evotec’s technology platforms in conjunction with the human iPSC based platform, which is one of the largest and most sophisticated platforms in the industry. The iPSC partnership between BMS and Evotec has already been expanded with additional cell lines several times.

Dr. Cord Dohrmann, chief scientific officer of Evotec, said, “We are very pleased about this latest expansion of our iPSC-alliance with Bristol-Myers Squibb. Patient-derived disease models will be instrumental to improving the translatability of pre-clinical discovery efforts into clinical benefits and we are proud to leverage our proprietary iPSC platform together with Bristol-Myers Squibb for the benefit of the patients.”


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics